Charles River (CRL) Beats Q3 Views by 5c; Lowers FY09 EPS Guidance
More News related to CRL
- Barclays Downgrades Charles River Labs (CRL) to Equal Weight
- Morning Movers 11/04: MPAC, ABK, GNVC, RHB, IRE, PACR Higher; STEC, CLRT, VG, TRLG, ANSW Lower
- After-Hours Movers 11/03: QLTY, PACR, BGCP, TESO Higher; STEC, TRLG, CLRT, CRL, MYGN Lower
- Charles River (CRL) Beats Q3 Views by 5c; Lowers FY09 EPS Guidance
- Charles River Announces Third-Quarter 2009 Results
More News related to Earnings
- Hemispherx (HEB) Shares Breaking Out as $1 Technical Level Holds; Stock Up 23%
- Activision's (ATVI) Call of Duty Amasses $3 Billion in Global Sales
- Casino Stocks Tumble Sharply Amid Dubai Concerns (MGM, LVS, WYNN)
- Dubai Fallout ETF Trades
- Apple (AAPL) Shares to Open Below $200 as Dubai World Debt Weighs on Stocks
Charles River Laboratories International, Inc. (NYSE: CRL) reports Q3 adjusted EPS of $0.65, 5 cents better than the analyst estimate of $0.60. Revenue for the quarter was $297 million, which compares to the estimate of $306.95 million.
Lower FY09 EPS guidance to $2.28 - $2.32, versus $2.42 consensus.
Related Categories
EarningsGuidance
Stocks Mentioned
-0.25Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
